The first hepatitis B vaccine was approved by the FDA. However, it wasn’t until 1986 that the recombinant version came to market to replace the original vaccines. A few years later in 1991, the US began to push widespread adoption of the HBV vaccines to reduce the associated morbidity and mortality.